Neurociencias
Departamento
KOEN
VANDENBROECK
VISITANTE IKERBASQUE
Publicaciones en las que colabora con KOEN VANDENBROECK (19)
2022
-
Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
Frontiers in Immunology, Vol. 12
2020
-
Birc6 is associated with vulnerability of carotid atherosclerotic plaque
International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-13
-
The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis
Cells, Vol. 9, Núm. 1
2019
-
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease
PLoS Genetics, Vol. 15, Núm. 6
-
Interactome of the Autoimmune Risk Protein ANKRD55
Frontiers in Immunology, Vol. 10
-
Pharmacological targeting of the er-resident chaperones GRP94 or cyclophilin b induces secretion of IL-22 binding protein isoform-1 (IL-22bpi1)
International Journal of Molecular Sciences, Vol. 20, Núm. 10
2016
-
Analysis of plasminogen genetic variants in multiple sclerosis patients
G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079
-
Novel insights into the multiple sclerosis risk gene ANKRD55
Journal of Immunology, Vol. 196, Núm. 11, pp. 4553-4565
2015
-
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627
-
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 12, pp. 1498-1512
-
Genome-wide significant association with seven novel multiple sclerosis risk loci
Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855
-
Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154
2014
-
Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology
PLoS ONE, Vol. 9, Núm. 12
-
Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: A meta-analysis
PLoS ONE, Vol. 9, Núm. 3
2013
-
TNFRSF1A polymorphisms rs1800693 and rs4l49584 in patients with multiple sclerosis
Neurology, Vol. 80, Núm. 22, pp. 2010-2016
2012
-
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis
Genes and Immunity, Vol. 13, Núm. 1, pp. 21-28
-
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990
2008
-
Pharmacogenomics of the response to IFN-β in multiple sclerosis: Ramifications from the first genome-wide screen
Pharmacogenomics, Vol. 9, Núm. 5, pp. 639-645
2005
-
Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: A study in Spanish-Basque, Northern Irish and Belgian populations
International Journal of Immunogenetics, Vol. 32, Núm. 6, pp. 383-388